Alicia Ciccone

gammaCore, a hand-held device for treating episodic cluster headaches via mild electrical stimulation of the vagus nerve is now available in the United States.

In a 3-year period, 45% of patients with trigeminal neuralgia received at least 3 unique treatments.

The topical gel may be suitable for patients who experience gastrointestinal side effects from oral NSAIDs.

Psychiatric comorbidities, which often aren’t diagnosed until teenage years, seemed to attribute to prolonged recoveries.

The well-tolerated treatment helped sustain migraine relief more than 48-hours post-dose.